n-(4,6-dimethyl-2-pyridinyl)benzamide has been researched along with metoclopramide in 1 studies
| Studies (n-(4,6-dimethyl-2-pyridinyl)benzamide) | Trials (n-(4,6-dimethyl-2-pyridinyl)benzamide) | Recent Studies (post-2010) (n-(4,6-dimethyl-2-pyridinyl)benzamide) | Studies (metoclopramide) | Trials (metoclopramide) | Recent Studies (post-2010) (metoclopramide) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 5,044 | 1,216 | 623 |
| Protein | Taxonomy | n-(4,6-dimethyl-2-pyridinyl)benzamide (IC50) | metoclopramide (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 2.383 | |
| Myeloperoxidase | Homo sapiens (human) | 0.35 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 2.721 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.8 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.127 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 7.8 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 7.8 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 7.7 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 7.7 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 7.7 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 7.8 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 3.675 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 2.383 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 7.8 | |
| 5-hydroxytryptamine receptor 1D | Rattus norvegicus (Norway rat) | 7.8 | |
| 5-hydroxytryptamine receptor 1F | Rattus norvegicus (Norway rat) | 7.8 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.2 | |
| 5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | 0.88 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.63 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 7.8 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.6237 | |
| 5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | 0.88 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouhayat, S; Le Baut, G; Petit, JY; Piessard, S; Piriou, F; Sparfel, L; Welin, L | 1 |
1 other study(ies) available for n-(4,6-dimethyl-2-pyridinyl)benzamide and metoclopramide
| Article | Year |
|---|---|
Synthesis and central dopaminergic effects of N-(4,6-dimethyl-2-pyridinyl)benzamides.
Topics: alpha-Methyltyrosine; Animals; Apomorphine; Benzamides; Brain; Corpus Striatum; Dopamine; Dopamine Antagonists; Homovanillic Acid; Humans; Limbic System; Male; Methyltyrosines; Mice; Motor Activity; Pyridines; Rats; Rats, Inbred Strains; Reserpine; Stereotyped Behavior | 1985 |